Dr Ronald D Gardner, PSYD | |
25647 Redwood Hwy, Cave Junction, OR 97531-9724 | |
(541) 592-4111 | |
(541) 592-3916 |
Full Name | Dr Ronald D Gardner |
---|---|
Gender | Male |
Speciality | Psychologist |
Location | 25647 Redwood Hwy, Cave Junction, Oregon |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306910948 | NPI | - | NPPES |
127725 | Medicaid | OR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103T00000X | Psychologist | 1372 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Ronald D Gardner, PSYD Po Box 158, Grants Pass, OR 97528-0012 Ph: (541) 592-4111 | Dr Ronald D Gardner, PSYD 25647 Redwood Hwy, Cave Junction, OR 97531-9724 Ph: (541) 592-4111 |
News Archive
Professor Colin Pritchard's latest research published in Public Health Journal has found that the sharp rise of dementia and other neurological deaths in people under 74 cannot be put down to the fact that we are living longer - the rise is because a higher proportion of old people are being affected by such conditions, and what is really alarming, it is starting earlier and affecting people under 55 years.
These days, it can be difficult for anyone to find a job – let alone a career in which you can really help others. However, even as the job market seems stagnant in almost every field, there is a growing need for licensed vocational nurses and other health workers.
In today's fast-paced health care environment, it is critical that hospitals keep their staff updated on using the latest imaging technology available. Currently, most facilities receive the majority of their diagnostic imaging equipment training when a new system is delivered. Toshiba America Medical Systems, Inc. recognizes the importance of maintaining that training edge and now is providing customers with an option – Performance Plus.
Janssen Pharmaceuticals, Inc. announced today that the company has entered into a definitive collaboration and license agreement with Bavarian Nordic to leverage their MVA-BN technology, jointly with Janssen's own AdVac® technology, in the development and commercialization of a heterologous prime-boost vaccine for the treatment of Human Papillomavirus (HPV) chronic infections which can lead to cancer.
Imagine a sensor implanted in your body that signals when you're getting sick - almost like the "check engine" light in a car. That scenario sounds like pure fantasy, but it may be closer to reality than many people think, according to an article in the current edition of Chemical & Engineering News, ACS' weekly newsmagazine.
› Verified 1 days ago